drugset / Trial / NCT00517556
Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary hypothesis is that continuous administration of an OCP (CCOCP regimen) will result in more pain relief than a traditional 21/7 administration in primary dysmenorrhea (PD) patients.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-03
- Completion
- 2011-04
Publications
- Schroll JB, Black AY, Farquhar C, Chen I. Combined oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2023 Jul 31;7(7):CD002120. doi: 10.1002/14651858.CD002120.pub4.
- Dmitrovic R, Kunselman AR, Legro RS. Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol. 2012 Jun;119(6):1143-50. doi: 10.1097/AOG.0b013e318257217a.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gestodene | Small molecule | 0.075 mg | Oral |
| Comparator | ethinyl estradiol | Small molecule | 20 ug | Oral |